Severe COVID-19 appears rare in children. This is unexpected, especially in young infants, who are vulnerable to severe disease caused by other respiratory viruses. We evaluate convalescent immune responses in 4 infants under 3 months old with confirmed COVID-19 who presented with mild febrile illness, alongside their parents, and adult controls recovered from confirmed COVID-19. Although not statistically significant, compared to seropositive adults, infants have high serum levels of IgG and IgA to SARS-CoV-2 spike protein, with a corresponding functional ability to block SARS-CoV-2 cellular entry. Infants also exhibit robust saliva anti-spike IgG and IgA responses. Spike-specific IFN-γ production by infant peripheral blood mononuclear cells appears restrained, but the frequency of spike-specific IFN-γ- and/or TNF-α-producing T cells is comparable between infants and adults. On principal-component analysis, infant immune responses appear distinct from their parents. Robust functional antibody responses alongside restrained IFN-γ production may help protect infants from severe COVID-19.

Young infants exhibit robust functional antibody responses and restrained IFN-γ production to SARS-CoV-2 / Goenka, A.; Halliday, A.; Gregorova, M.; Milodowski, E.; Thomas, A.; Williamson, M. K.; Baum, H.; Oliver, E.; Long, A. E.; Knezevic, L.; Williams, A. J. K.; Lampasona, V.; Piemonti, L.; Gupta, K.; Di Bartolo, N.; Berger, I.; Toye, A. M.; Vipond, B.; Muir, P.; Bernatoniene, J.; Bailey, M.; Gillespie, K. M.; Davidson, A. D.; Wooldridge, L.; Rivino, L.; Finn, A.. - In: CELL REPORTS MEDICINE. - ISSN 2666-3791. - (2021), p. 100327. [Epub ahead of print] [10.1016/j.xcrm.2021.100327]

Young infants exhibit robust functional antibody responses and restrained IFN-γ production to SARS-CoV-2

Piemonti L.;
2021-01-01

Abstract

Severe COVID-19 appears rare in children. This is unexpected, especially in young infants, who are vulnerable to severe disease caused by other respiratory viruses. We evaluate convalescent immune responses in 4 infants under 3 months old with confirmed COVID-19 who presented with mild febrile illness, alongside their parents, and adult controls recovered from confirmed COVID-19. Although not statistically significant, compared to seropositive adults, infants have high serum levels of IgG and IgA to SARS-CoV-2 spike protein, with a corresponding functional ability to block SARS-CoV-2 cellular entry. Infants also exhibit robust saliva anti-spike IgG and IgA responses. Spike-specific IFN-γ production by infant peripheral blood mononuclear cells appears restrained, but the frequency of spike-specific IFN-γ- and/or TNF-α-producing T cells is comparable between infants and adults. On principal-component analysis, infant immune responses appear distinct from their parents. Robust functional antibody responses alongside restrained IFN-γ production may help protect infants from severe COVID-19.
2021
antibody
COVID-19
immunity
infant
T cell
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/117674
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 23
social impact